Bide Pharmatech Co., Ltd. (SHA:688073)
China
· Delayed Price · Currency is CNY 59.73
+1.68 (2.89%)
Apr 29, 2026, 4:00 PM EDT
Bide Pharmatech Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Market Capitalization | 5,146 | 5,260 | 4,342 | 5,044 | 5,333 | - | Upgrade
|
| Market Cap Growth | 17.13% | 21.13% | -13.91% | -5.42% | - | - | Upgrade
|
| Enterprise Value | 4,245 | 4,347 | 3,260 | 3,905 | 3,860 | - | Upgrade
|
| Last Close Price | 59.73 | 61.05 | 48.17 | 52.79 | 55.15 | - | Upgrade
|
| PE Ratio | 34.53 | 34.66 | 36.98 | 46.03 | 36.53 | - | Upgrade
|
| Forward PE | 25.26 | 27.56 | 31.74 | 22.50 | 30.12 | - | Upgrade
|
| PS Ratio | 3.89 | 3.97 | 3.94 | 4.62 | 6.40 | - | Upgrade
|
| PB Ratio | 2.52 | 2.57 | 2.14 | 2.41 | 2.57 | - | Upgrade
|
| P/TBV Ratio | 2.53 | 2.59 | 2.15 | 2.42 | 2.57 | - | Upgrade
|
| P/FCF Ratio | 1273.64 | 1301.79 | 62.06 | - | - | - | Upgrade
|
| P/OCF Ratio | 181.68 | 185.69 | 27.43 | - | 178.53 | - | Upgrade
|
| EV/Sales Ratio | 3.21 | 3.28 | 2.96 | 3.58 | 4.63 | - | Upgrade
|
| EV/EBITDA Ratio | 16.36 | 16.97 | 26.38 | 35.88 | 25.71 | - | Upgrade
|
| EV/EBIT Ratio | 17.57 | 17.99 | 28.92 | 39.33 | 26.74 | - | Upgrade
|
| EV/FCF Ratio | 1050.78 | 1075.81 | 46.59 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.07 | 0.04 | 0.03 | 0.02 | 0.04 | Upgrade
|
| Debt / EBITDA Ratio | 0.54 | 0.54 | 0.58 | 0.45 | 0.25 | 0.23 | Upgrade
|
| Debt / FCF Ratio | 34.92 | 34.92 | 1.18 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | -0.44 | -0.44 | -0.54 | -0.58 | -0.71 | -0.26 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.51 | -3.51 | -8.89 | -11.18 | -9.78 | -1.49 | Upgrade
|
| Net Debt / FCF Ratio | -222.86 | -222.86 | -15.70 | 10.27 | 172.02 | 1.76 | Upgrade
|
| Asset Turnover | 0.54 | 0.54 | 0.46 | 0.46 | 0.51 | 0.86 | Upgrade
|
| Inventory Turnover | 0.85 | 0.85 | 0.93 | 1.10 | 0.94 | 0.91 | Upgrade
|
| Quick Ratio | 3.86 | 3.86 | 4.12 | 5.54 | 6.84 | 1.31 | Upgrade
|
| Current Ratio | 6.74 | 6.74 | 6.39 | 8.22 | 9.01 | 3.28 | Upgrade
|
| Return on Equity (ROE) | 7.45% | 7.45% | 5.71% | 5.21% | 10.79% | 19.65% | Upgrade
|
| Return on Assets (ROA) | 6.12% | 6.12% | 2.92% | 2.60% | 5.53% | 9.51% | Upgrade
|
| Return on Invested Capital (ROIC) | 16.79% | 18.10% | 9.93% | 11.55% | 22.92% | 25.82% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.10% | 11.10% | 5.40% | 4.60% | 6.80% | 16.40% | Upgrade
|
| Earnings Yield | 2.95% | 2.89% | 2.70% | 2.17% | 2.74% | - | Upgrade
|
| FCF Yield | 0.08% | 0.08% | 1.61% | -2.35% | -0.16% | - | Upgrade
|
| Dividend Yield | 1.55% | - | 1.87% | 1.70% | 1.99% | - | Upgrade
|
| Payout Ratio | 52.58% | 52.58% | 68.03% | 91.29% | 0.06% | 0.19% | Upgrade
|
| Buyback Yield / Dilution | 1.40% | 1.40% | 1.76% | -22.83% | -10.09% | -8.03% | Upgrade
|
| Total Shareholder Return | 2.95% | 1.40% | 3.63% | -21.13% | -8.10% | -8.03% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.